GSA Capital Partners LLP Grows Stock Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)

GSA Capital Partners LLP lifted its stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 136.8% during the 1st quarter, Holdings Channel reports. The institutional investor owned 87,284 shares of the company’s stock after buying an additional 50,427 shares during the period. GSA Capital Partners LLP’s holdings in Syndax Pharmaceuticals were worth $1,072,000 at […]

Leave a Reply

Your email address will not be published.

Previous post Norden Group LLC Buys 19,947 Shares of Ready Capital Corp (NYSE:RC)
Next post Federated Hermes Inc. Sells 3,559 Shares of FTI Consulting, Inc. (NYSE:FCN)